ERBB2 and breast cancer: One prominent hallmark of HER2-positive breast cancer is the overexpression of HER2, which sustains the generation of signals promoting cell survival and proliferation through self-dimerization and the activation of downstream pathways, including PI3K-AKT-mTOR and RAS-RAF cascades [5].